Patents Assigned to Sepacor Inc.
  • Patent number: 5936124
    Abstract: A synthesis of fluoxetine is disclosed. The process begins with a lower alkyl ester of 3-benzoylpropionic acid, which is reduced in the presence of a chiral ligand to produce the corresponding .gamma.-hydroxy ester, and the ester is cleaved. The free acid is then condensed with the alcohol to form a .gamma.-lactone, which is treated with ammonia to provide the .gamma.-hydroxy amide. The amide undergoes a Hoffman rearrangement to provide a 2-oxo-1,3 oxazine, which is reduced to 3-(methylamino)-1-phenyl-1-propanol. The alcohol is deprotonated and reacted with a 4-chloro- or 4-fluoro benzotrifluoride to provide fluoxetine free base.
    Type: Grant
    Filed: June 22, 1998
    Date of Patent: August 10, 1999
    Assignee: Sepacor Inc.
    Inventors: James Wallace Hilborn, Alex Roger Jurgens, Chris Hugh Senanayake